Prof. Hilde Nelissen (Group leader at the VIB-UGent Center for Plant Systems Biology) and Giacomo Bastianelli (CEO of Rainbow Crops).

Rainbow Crops raises €9.7M seed round to scale AI-driven multiplex gene editing for next-generation crops

The round was led by Italian venture capital company LIFTT, together with its vehicle LIFTT EuroInvest

Ghent, Belgium - 16 June 2026 - Rainbow Crops, a next-generation agtech company developing improved crop varieties by engineering complex agronomic traits, today announced it has raised €9.7 million to further advance its technology platform, expand its application across multiple crops, and scale the team. The funding will accelerate the company’s AI-supported multiplex genome editing capabilities, support the deployment of its platform in key crops, and strengthen the team across both scientific and technical functions to drive execution.

The oversubscribed seed funding round was led by Italian venture capital company LIFTT, together with its vehicle LIFTT EuroInvest, with participation from existing investors AIF (Agri Investment Fund), PINC, and VIB, as well as new investors Corteva, through its Corteva Catalyst investment platform, and Maia Ventures, signalling strong investor interest and confidence in Rainbow Crops’ technology platform. The seed funding round follows Rainbow Crops’ recent $7M grant from the Gates Foundation.

Engineering complex traits at scale

While traditional breeding has delivered major gains in the past decades, engineering complex traits remains slow, expensive, and difficult to predict. As climate volatility increases, input costs fluctuate, and regulatory shifts enable the wider adoption of gene editing, crop developers are under growing pressure to deliver more predictable performance in less time.

Rainbow Crops’ proprietary Trait Foundryplatform integrates artificial intelligence, multiplex genome editing, precision breeding, and automated phenotyping to systematically identify, generate, and evaluate combinations of genetic variants underlying complex agronomic traits such as yield or stress resilience. By combining multiplex genome editing with breeding, the platform creates populations of plants with rationally designed genetic diversity, enabling the efficient exploration and selection of multi-gene trait architectures at scale. Proof of concept has been obtained in corn.

This investment allows us to accelerate the transition from early validation to systematic deployment of our platform”, said Giacomo Bastianelli, CEO and Co-founder of Rainbow Crops. "Our goal is to accelerate complex trait engineering and make it accessible to partners globally.” “This round signals strong external validation and positions Rainbow Crops as an emerging category leader in AI-driven, multiplex genome engineering”, added Bastianelli. “We are now focused on innovative partnerships and on delivering real-world impact in the field.”
Edoardo Bianchi, Project Manager at LIFTT, said, “Rainbow Crops is a compelling example of breakthrough innovation in agritech - a category-defining platform that integrates AI, genome editing, and real-world validation to address critical crop breeding challenges. At LIFTT, we are proud to support and invest in such a visionary project.”

The investors were attracted by Rainbow Crops’ potential to significantly accelerate the development of climate-resilient and high-performing crop varieties. This is underpinned by early field validation in major crops such as corn, a growing proprietary data advantage, and strong validation through engagement with leading seed companies, backing from the Gates Foundation, and access to VIB’s scientific expertise and research infrastructure.


Notes to editors

To download high-res images and view investor boilerplates and biographies, please visit this link.

 

For further press information and to arrange interviews, please contact:

Daniel Brew

Account ​ Manager

daniel.brew@ederalab.com

Kurian Jacob

Account Executive

kurian.jacob@ederalab.com

Kristof Windels

Media Relations Manager, VIB

 

 

About Rainbow Crops

Rainbow Crops is a next-generation agtech company developing climate-resilient, high-performing crop varieties through its proprietary Trait Foundry platform. By integrating multiplex genome editing, artificial intelligence, precision breeding, and automated phenotyping, Rainbow Crops enables the systematic engineering of complex agronomic traits. The company collaborates with seed and breeding partners to advance sustainable agriculture and global food security. Founded in 2025 as a spin-off from the VIB–UGent Center for Plant Systems Biology, Rainbow Crops builds on years of publicly supported research and operates within VIB’s advanced research infrastructure.

Learn more at www.rainbowcrops.com

 

Share

Latest stories

Website preview
Researchers identify a key biological tipping point in Alzheimer’s disease
Leuven, 4 June 2026 – Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical biological transition that may determine whether Alzheimer’s disease pathology leads to dementia. Studying brain tissue from older adults with and without cognitive decline, as well as cognitively healthy centenarians, the team identified distinct cellular programs and immune-cell states associated with disease progression and resilience. Their findings, published in Nature Medicine, suggest that changes in microglia—the brain’s resident immune cells—could represent an important target for future Alzheimer’s therapies.
press.vib.be
Website preview
Prof. Diether Lambrechts (KU Leuven/VIB) receives the Francqui-Collen Prize 2026
Brussels, June 2, 2026 – Prof. Dr. Diether Lambrechts (KU Leuven/VIB) and Prof. Dr. Patrice Cani (UCLouvain) are the laureates of the Francqui-Collen Prize 2026, one of the highest scientific distinctions in Belgium. Today, they receive the award from the hands of King Philippe. Prof. Lambrechts is being honored for his groundbreaking genetic research into cancer treatments, while Prof. Cani is recognized for his discoveries regarding the impact of gut bacteria on lifestyle-related diseases.
press.vib.be
Website preview
Comprehensive atlas maps dendritic cells across cancers
Brussels, 01 June 2026 — Researchers from VIB, VUB, and an international network of collaborators have created the most comprehensive single-cell atlas to date of tumor-associated dendritic cells. By integrating data from 14 mouse tumor models and 10 human cancer types, the study provides a detailed, cross-species view of how these key immune cells are organized and altered in cancer. This work, which appeared in Nature Communications, can guide the development of next-generation therapies.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be